Continuous Hemodiafiltration with Polymyxin‐B Immobilized Fiber Is Effective in Patients with Sepsis Syndrome and Acute Renal Failure
- 1 June 2002
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis
- Vol. 6 (3), 234-240
- https://doi.org/10.1046/j.1526-0968.2002.00416.x
Abstract
The aim of this study was first, to evaluate the effects of continuous hemodiafiltration (CHDF) alone or combined with CHDF and polymyxin‐B immobilized fiber (PMX) on survival rates of pati...Keywords
This publication has 32 references indexed in Scilit:
- Pathophysiology of Septic Shock and Multiple Organ Dysfunction Syndrome and Various Therapeutic Approaches with Special Emphasis on ImmunoglobulinsTherapeutic Apheresis, 2001
- Apheresis as Therapy for Patients with Severe Sepsis and Multiorgan Dysfunction SyndromeTherapeutic Apheresis, 2001
- Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at riskCritical Care Medicine, 1996
- Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substancesKidney International, 1995
- Sepsis and controlled clinical trialsCritical Care Medicine, 1995
- Another negative clinical trial of a new agent for the treatment of sepsisCritical Care Medicine, 1995
- Management of septic shockJournal of Infection, 1995
- Continuous hemofiltration in severe sepsis: Is it beneficial?Journal of Critical Care, 1995
- Treatment of Sepsis-Associated Severe Acute Renal Failure with Continuous Hemodiafiltration: Clinical Experience and Comparison with Conventional DialysisBlood Purification, 1995
- The Potential Role of Hemofiltration in the Treatment of Patients With Septic Shock and Multiple Organ Dysfunction SyndromeAdvances in Renal Replacement Therapy, 1994